CO6270365A2 - Derivado heterociclico con una sal farmaceuticamente aceptable o solvato del mismo y composicion que lo comprende - Google Patents
Derivado heterociclico con una sal farmaceuticamente aceptable o solvato del mismo y composicion que lo comprendeInfo
- Publication number
- CO6270365A2 CO6270365A2 CO10057470A CO10057470A CO6270365A2 CO 6270365 A2 CO6270365 A2 CO 6270365A2 CO 10057470 A CO10057470 A CO 10057470A CO 10057470 A CO10057470 A CO 10057470A CO 6270365 A2 CO6270365 A2 CO 6270365A2
- Authority
- CO
- Colombia
- Prior art keywords
- pharmaceutically acceptable
- heterociclical
- derivative
- composition
- same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
La presente invencion se relaciona con un derivado heterociclico de acuerdo con la formula (I) en donde las variables se definen como en la especificacion, o con una sal farmacéuticamente aceptable o solvato del mismo. La presente invencion también se relaciona con una composicion farmacéutica que comprende dichos derivados heterociclicos y con su uso en terapia, por ejemplo en el tratamiento o prevencion de enfermedades siquiatricas donde se requiera una mejora de las respuestas sinapticas mediadas por los receptores AMPA, que incluyen esquizofrenia, depresion y trastornos de aprendizaje y memoria tales como enfermedad de Alzheimer.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07120603 | 2007-11-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6270365A2 true CO6270365A2 (es) | 2011-04-20 |
Family
ID=39472607
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO10057470A CO6270365A2 (es) | 2007-11-13 | 2010-05-13 | Derivado heterociclico con una sal farmaceuticamente aceptable o solvato del mismo y composicion que lo comprende |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8129397B2 (es) |
| EP (1) | EP2209791B1 (es) |
| JP (1) | JP5455130B2 (es) |
| KR (1) | KR20100106370A (es) |
| CN (1) | CN101855227B (es) |
| AR (1) | AR069286A1 (es) |
| AU (1) | AU2008322986B2 (es) |
| BR (1) | BRPI0819202A2 (es) |
| CA (1) | CA2703901C (es) |
| CL (1) | CL2008003362A1 (es) |
| CO (1) | CO6270365A2 (es) |
| EC (1) | ECSP10010247A (es) |
| MX (1) | MX2010004686A (es) |
| PE (1) | PE20091167A1 (es) |
| RU (1) | RU2010123895A (es) |
| TW (1) | TW200934497A (es) |
| WO (1) | WO2009062930A1 (es) |
| ZA (1) | ZA201002580B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200934497A (en) | 2007-11-13 | 2009-08-16 | Organon Nv | Heterocyclic derivatives |
| US12006328B2 (en) | 2014-11-18 | 2024-06-11 | Emory University | Thieno[2,3-d]pyrimidin-4-one derivatives as NMDAR modulators and uses related thereto |
| RS60834B1 (sr) | 2015-12-09 | 2020-10-30 | Cadent Therapeutics Inc | Modulatori heteroaromatskog nmda receptora i njihove upotrebe |
| EP4006038A1 (en) | 2015-12-09 | 2022-06-01 | Cadent Therapeutics, Inc. | Thienopyrimidinone nmda receptor modulators and uses thereof |
| WO2018119374A1 (en) | 2016-12-22 | 2018-06-28 | Cadent Therapeutics | Nmda receptor modulators and uses thereof |
| GB201702221D0 (en) * | 2017-02-10 | 2017-03-29 | Univ Of Sussex | Compounds |
| GB201803340D0 (en) | 2018-03-01 | 2018-04-18 | Univ Of Sussex | Compounds |
| CR20210125A (es) | 2018-08-03 | 2021-06-30 | Cadent Therapeutics Inc | Moduladores del receptor nmda heteroaromático y usos de los mismos |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE430729T1 (de) * | 2003-10-08 | 2009-05-15 | Lilly Co Eli | Pyrrol- und pyrazolderivate als potentiatoren von glutamatrezeptoren |
| ATE552251T1 (de) | 2004-01-09 | 2012-04-15 | Lilly Co Eli | Thiophen- und furanverbindungen |
| CN101171235B (zh) * | 2005-03-16 | 2011-03-02 | 安万特药物公司 | 作为中枢神经系统活性剂的联吡唑类 |
| GB0507298D0 (en) * | 2005-04-11 | 2005-05-18 | Novartis Ag | Organic compounds |
| EP1908765B1 (en) * | 2005-06-14 | 2014-10-22 | ASKA Pharmaceutical Co., Ltd. | Thienopyrimidine derivative |
| TW200934497A (en) | 2007-11-13 | 2009-08-16 | Organon Nv | Heterocyclic derivatives |
-
2008
- 2008-10-28 TW TW097141383A patent/TW200934497A/zh unknown
- 2008-11-11 CA CA2703901A patent/CA2703901C/en active Active
- 2008-11-11 WO PCT/EP2008/065306 patent/WO2009062930A1/en active Application Filing
- 2008-11-11 MX MX2010004686A patent/MX2010004686A/es not_active Application Discontinuation
- 2008-11-11 EP EP08849917.3A patent/EP2209791B1/en active Active
- 2008-11-11 RU RU2010123895/04A patent/RU2010123895A/ru unknown
- 2008-11-11 JP JP2010533556A patent/JP5455130B2/ja active Active
- 2008-11-11 CN CN2008801156861A patent/CN101855227B/zh active Active
- 2008-11-11 BR BRPI0819202 patent/BRPI0819202A2/pt not_active IP Right Cessation
- 2008-11-11 KR KR1020107012728A patent/KR20100106370A/ko not_active Application Discontinuation
- 2008-11-11 AU AU2008322986A patent/AU2008322986B2/en active Active
- 2008-11-12 AR ARP080104926A patent/AR069286A1/es unknown
- 2008-11-12 US US12/269,306 patent/US8129397B2/en active Active
- 2008-11-12 PE PE2008001915A patent/PE20091167A1/es not_active Application Discontinuation
- 2008-11-12 CL CL2008003362A patent/CL2008003362A1/es unknown
-
2010
- 2010-04-13 ZA ZA2010/02580A patent/ZA201002580B/en unknown
- 2010-05-13 CO CO10057470A patent/CO6270365A2/es not_active Application Discontinuation
- 2010-06-11 EC EC2010010247A patent/ECSP10010247A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2010123895A (ru) | 2011-12-20 |
| KR20100106370A (ko) | 2010-10-01 |
| CA2703901C (en) | 2016-05-10 |
| JP2011503139A (ja) | 2011-01-27 |
| WO2009062930A1 (en) | 2009-05-22 |
| AU2008322986B2 (en) | 2013-08-01 |
| PE20091167A1 (es) | 2009-08-03 |
| CA2703901A1 (en) | 2009-05-22 |
| ECSP10010247A (es) | 2010-07-30 |
| EP2209791B1 (en) | 2014-01-22 |
| CL2008003362A1 (es) | 2009-06-26 |
| ZA201002580B (en) | 2010-12-29 |
| CN101855227B (zh) | 2013-01-23 |
| AR069286A1 (es) | 2010-01-13 |
| EP2209791A1 (en) | 2010-07-28 |
| AU2008322986A1 (en) | 2009-05-22 |
| US20090131455A1 (en) | 2009-05-21 |
| CN101855227A (zh) | 2010-10-06 |
| US8129397B2 (en) | 2012-03-06 |
| JP5455130B2 (ja) | 2014-03-26 |
| MX2010004686A (es) | 2010-05-19 |
| TW200934497A (en) | 2009-08-16 |
| BRPI0819202A2 (pt) | 2015-05-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6270365A2 (es) | Derivado heterociclico con una sal farmaceuticamente aceptable o solvato del mismo y composicion que lo comprende | |
| IN2012DN02968A (es) | ||
| NI200900204A (es) | COMPUESTOS AMINO-HETEROCÍCLICOS. Caso: PC 33468A | |
| DOP2011000135A (es) | Moduladores de aril metil benzoquinazolinona alostericos positivos del receptor m1 | |
| CO6501188A2 (es) | Moduladores de piranil aril metil benzoquinazolina alostéricos positivos del receptos m1 | |
| PE20181010A1 (es) | Derivados de n-[2-(1-benzilpiperidin-4-il)etil]-4-(pirazin-2-il)-piperazina-1-carboxamida y compuestos relacionados como antagonistas del receptor muscarinico 4 (m4) para tratar trastornos neurologicos | |
| GT201300179A (es) | Derivados heterociclicos novedosos y su uso en el tratamiento de trastornos neurologicos | |
| SV2006002055A (es) | Compuestos de imidazol para el tratamiento de trastornos neurodegenerativos ref. pc32054a | |
| HN2012001413A (es) | Derivados de pirazina y su uso en el tratamiento de trastornos neurólogicos | |
| UY30411A1 (es) | Derivados sustituidos del acetato de 2,3,4,-tetrahidroimidazo-[1,5-a]-pirimidin-6-amina, composiciones farmacéuticas y aplicaciones | |
| UY30641A1 (es) | Derivados de 2-[1h-pirazol-5-il] y de 2-[2h-pirazol-3-il]tieno[3,2-c]piridinas sustituidas, sus sales farmaceuticamente aceptables y aplicaciones | |
| AR077252A1 (es) | Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos | |
| DOP2006000169A (es) | Inhibidores espiropiperidina de beta-secretasa para el tratamiento de la enfermedad de alzheimer | |
| ECSP12011622A (es) | Derivados de oxazina y su uso como inhibidores de bace para el tratamiento de trastornos neurológicos | |
| UY30058A1 (es) | (indazol-5-il)-piracinas y (1,3-dihidro-indol-2-on)-piracinas para el tratamiento de enfermedades y afecciones mediadas por la rho quinasa | |
| CR10420A (es) | Derivados biciclicos como inhibibidores de cetp | |
| ECSP088283A (es) | Compuestos de piridina 5- (fenilisoxazoliletoxi) -triazol- 3-ilo substituidos para el tratamiento de trastornos neurológicos, psiquiátricos o del dolor | |
| CR10250A (es) | Derivados de amida y su aplicación para el tratamiento de enfermedades relacionadas con proteína-g | |
| ECSP077424A (es) | Derivados de quinuclidina y su uso como antagonistas del receptor muscarínico m3 | |
| BRPI0416989A (pt) | derivados aminopirazole como inibidores gsk-3 | |
| WO2009050242A3 (de) | Heterocyclus-substituierte piperazino-dihydrothienopyrimidine | |
| BRPI0514735A (pt) | derivados de piridino sulfonamida como moduladores do receptor de quimiocina | |
| ECSP088541A (es) | [(1h-indol-5-il)-heteroariloxi]-(1-aza-biciclo[3.3.1]nonanos como ligandos colinérgicos del n-achr para el tratamiento de trastornos psicóticos y neurodegenerativos | |
| CL2019001891A1 (es) | Derivados de bis-heteroarilo bicíclicos como moduladores de agregación de proteínas. | |
| CO2021002976A2 (es) | Amidas heterocíclicas de 5 a 7 miembros como inhibidores de jak |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Application withdrawn |